A Solomon

Summary

Affiliation: University of Kuopio
Country: Finland

Publications

  1. doi Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease
    Alina Solomon
    Department of Neurology, University of Kuopio, Kuopio, Finland
    Neurosci Lett 462:89-93. 2009
  2. ncbi Serum total cholesterol, statins and cognition in non-demented elderly
    A Solomon
    Department of Neurology, University of Kuopio, P O Box 1627 FIN 70211, Kuopio, Finland
    Neurobiol Aging 30:1006-9. 2009
  3. pmc Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort
    D Larry Sparks
    Roberts Laboratory for Neurodegenerative Disease Research, Sun Health Research Institute, Sun City, Ariz, USA
    Neurodegener Dis 7:183-6. 2010
  4. doi Cholesterol-modifying strategies for Alzheimer's disease
    Alina Solomon
    Aging Research Center, Karolinska Institutet, Sweden
    Expert Rev Neurother 9:695-709. 2009
  5. doi Lipid-lowering treatment is related to decreased risk of dementia: a population-based study (FINRISK)
    A Solomon
    Department of Neurology, University of Kuopio, PO Box 1627, FI 70211 Kuopio, Finland
    Neurodegener Dis 7:180-2. 2010
  6. pmc Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later
    Alina Solomon
    Department of Neurology, University of Kuopio, Kuopio, Finland
    Dement Geriatr Cogn Disord 28:75-80. 2009
  7. doi Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study
    B Hooshmand
    Aging Research Center, KarolinskaInstitutet, Stockholm, Sweden
    J Intern Med 271:204-12. 2012
  8. doi Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study
    B Hooshmand
    Aging Research Center, Department of Neurobiology, Care Sciences and Society NVS, Karolinska Institutet, Gavlegatan 16, S 113 30, Stockholm, Sweden
    Neurology 75:1408-14. 2010
  9. ncbi Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study
    A Solomon
    Department of Neuroscience and Neurology, University of Kuopio, Finland
    Neurology 68:751-6. 2007
  10. ncbi Advances in the prevention of Alzheimer's disease and dementia
    A Solomon
    Karolinska Institutet Alzheimer Disease Research Center KI ADRC, Stockholm, Sweden Department of Neurology, University of Eastern Finland, Kuopio, Finland
    J Intern Med 275:229-50. 2014

Detail Information

Publications14

  1. doi Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease
    Alina Solomon
    Department of Neurology, University of Kuopio, Kuopio, Finland
    Neurosci Lett 462:89-93. 2009
    ..This study investigates the relation of 24OHC as well as markers of extracerebral cholesterol homeostasis (lanosterol, lathosterol, cholesterol, LDL-C, HDL-C and 27-hydroxycholesterol) with brain volumes in memory clinic patients...
  2. ncbi Serum total cholesterol, statins and cognition in non-demented elderly
    A Solomon
    Department of Neurology, University of Kuopio, P O Box 1627 FIN 70211, Kuopio, Finland
    Neurobiol Aging 30:1006-9. 2009
    ..The association between serum total cholesterol (TC), lipid-lowering drugs and cognition in the elderly is currently controversial...
  3. pmc Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort
    D Larry Sparks
    Roberts Laboratory for Neurodegenerative Disease Research, Sun Health Research Institute, Sun City, Ariz, USA
    Neurodegener Dis 7:183-6. 2010
    ....
  4. doi Cholesterol-modifying strategies for Alzheimer's disease
    Alina Solomon
    Aging Research Center, Karolinska Institutet, Sweden
    Expert Rev Neurother 9:695-709. 2009
    ....
  5. doi Lipid-lowering treatment is related to decreased risk of dementia: a population-based study (FINRISK)
    A Solomon
    Department of Neurology, University of Kuopio, PO Box 1627, FI 70211 Kuopio, Finland
    Neurodegener Dis 7:180-2. 2010
    ..Several lines of evidence have linked cholesterol to dementia...
  6. pmc Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later
    Alina Solomon
    Department of Neurology, University of Kuopio, Kuopio, Finland
    Dement Geriatr Cogn Disord 28:75-80. 2009
    ..To investigate midlife cholesterol in relation to Alzheimer's disease (AD) and vascular dementia (VaD) in a large multiethnic cohort of women and men...
  7. doi Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study
    B Hooshmand
    Aging Research Center, KarolinskaInstitutet, Stockholm, Sweden
    J Intern Med 271:204-12. 2012
    ....
  8. doi Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study
    B Hooshmand
    Aging Research Center, Department of Neurobiology, Care Sciences and Society NVS, Karolinska Institutet, Gavlegatan 16, S 113 30, Stockholm, Sweden
    Neurology 75:1408-14. 2010
    ..To examine the relation between serum levels of homocysteine (tHcy) and holotranscobalamin (holoTC), the active fraction of vitamin B12, and risk of incident Alzheimer disease (AD) in a sample of Finnish community-dwelling elderly...
  9. ncbi Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study
    A Solomon
    Department of Neuroscience and Neurology, University of Kuopio, Finland
    Neurology 68:751-6. 2007
    ..Longitudinal studies have shown that high serum total cholesterol (TC) at midlife is a risk factor for dementia/Alzheimer disease. The significance of TC later in life is unclear...
  10. ncbi Advances in the prevention of Alzheimer's disease and dementia
    A Solomon
    Karolinska Institutet Alzheimer Disease Research Center KI ADRC, Stockholm, Sweden Department of Neurology, University of Eastern Finland, Kuopio, Finland
    J Intern Med 275:229-50. 2014
    ..The shift towards presymptomatic and pre-dementia stages of AD has brought prevention and treatment trials much closer to each other than before...
  11. ncbi Alzheimer's disease - the ways of prevention
    M Kivipelto
    Aging Research Center, Karolinska Institutet, Gavlegatan 16, S 113 30 Stockholm, Sweden
    J Nutr Health Aging 12:89S-94S. 2008
    ..The interplay of genes and environment in the aetiology of AD needs to be further investigated as well as the role of lifestyle and pharmacological interventions for the prevention of dementia...
  12. ncbi Alzheimer's Disease: back to the future
    M Kivipelto
    Department of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden
    Acta Neurol Scand Suppl 185:119-20. 2006
  13. ncbi Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence
    M Kivipelto
    Department of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden
    Acta Neurol Scand Suppl 185:50-7. 2006
    ....
  14. ncbi The new cholesterol controversy - a little bit of history repeating?
    M Kivipelto
    Department of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden
    Acta Neurol Scand Suppl 185:1-2. 2006